Amino acid utilisation and deamination of glutamine and asparagine by Helicobacter pylori

Journal of Medical Microbiology

Volumn 46, Issue 9, 1997, Pages 793-800

  Stark, R M ^a   Suleiman, M S ^b   Hassan, I J ^b   Greenman, J ^a   Millar, M R ^b  

^a UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ASPARAGINE; GLUTAMINE;

AMINO ACID ANALYSIS; AMINO ACID METABOLISM; ARTICLE; BACTERIAL METABOLISM; DEAMINATION; ENZYME ACTIVITY; ENZYME INHIBITION; HELICOBACTER PYLORI; NONHUMAN; PRIORITY JOURNAL;

EID: 0030928060     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/00222615-46-9-793     Document Type: Article

References (31)

1. Warren JR, Marshall B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983; 1: 1273-1275.
2. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1: 1311-1315.
3. Parsonnet J, Friedmen GD, Vandersteen DP et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325: 1127-1131.
4. Wotherspoon AC, Doglioni C, Diss TC et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa- associated lymphoid tissue after eradication of Helicobacter pylori. Lancet 1993; 342: 575-577.
5. Leunk RD, Johnson PT, David BC, Kraft WG, Morgan DR. Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. J Med Microbiol 1988; 26: 93-99.
6. Covacci A, Censini S, Bugnoli M et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA 1993; 90: 5791-5795.
7. Mégraud F, Bonnet F, Garnier M, Lamouliatte M. Characterization of "Campylobacter pylori" by culture, enzymic profile, and protein content. J Clin Microbiol 1985; 22: 1007-1010.
8. Hu L-T, Mobley HLT. Purification and N-terminal analysis of urease from Helicobacter pylori. Infect Immun 1990; 58: 992-998.
9. Dunn BE. Pathogenic mechanisms of Helicobacter pylori. Gasteroenterol Clin North Am 1993; 22: 43-57.
10. Mégraud F, Neman-Simha V, Brügmann D. Further evidence of the toxic effects of ammonia produced by Helicobacter pylori urease on human epithelial cells. Infect Immun 1992; 60: 1858-1863.
11. McNulty CAM, Dent JC. Rapid identification of Campylobacter pylori (C. pyloridis) by preformed enzymes. J Clin Microbiol 1987; 25: 1683-1686.
12. Mendz GL, Hazell SL, Bums BP. Glucose utilization and lactate production by Helicobacter pylori. J Gen Microbiol 1993; 139: 3023-3028.
13. Schaffer G, Stark R, Greenman J. Glucose metabolism by Helicobacter pylori (Comment). Microbiology 1994; 140: 2179.
14. Nedenskov P. Nutritional rerquirements for growth of Helicobacter pylori. Appl Environ Microbiol 1994; 60: 3450-3453.
15. Mendz GL, Hazell SL. Aminoacid utilization by Helicobacter pylori. Int J Biochem Cell Biol 1995; 27: 1085-1093.
16. Millar MR, Pike J. Bactericidal activity of antimicrobial agents against slowly growing Helicobacter pylori. Antimicrob Agents Chemother 1992; 36: 185-187.
17. Kangatharlingam N, Amy PS. Helicobacter pylori comb. nov. exhibits facultative acidophilism and obligate microaerophilism. Appl Environ Microbiol 1994; 60: 2176-2179.
18. Reynolds DJ, Penn CW. Characteristics of Helicobacter pylori growth in a defined medium and determination of its amino acid requirements. Microbiology 1994; 140: 2649-2656.
19. Weatherburn MW. Phenol-hypochlorite reaction for the determination of ammonia. Anal Chem 1967; 39: 971-974.
20. Suleiman M-S, Wallace D, Birkett S, Angelini GD. Changes in the intracellular free amino acid pool in human saphenous vein tissue culture. Exp Physiol 1996; 81: 435-446.
21. Roberts J, Holcenberg JS, Dolowy WC. Isolation, crystalization, and properties of Achromobacteraceae glutataminase- asparaginase with antitumor activity. J Biol Chem 1972; 247: 84-90.
22. Olivieri R, Bugnoli D, Armellini D et al. Growth of Helicobacter pylori in media containing cyclodextrins. J Clin Microbiol 1993; 31: 160-162.
23. Zollner H. Handbook of enzyme inhibitors. Cambridge, VCH Publishers (UK) Ltd. 1989.
24. Catrenich CE, Makin KM. Characterization of the morphologic conversion of Helicobacter pylori from bacillary to coccoid forms. Scand J Gasteroenterol 1991; 26 Suppl 181: 58-64.
25. Hodgins DS. Yeast phenylalanine ammonia-lyase. Purification, properties and the identification of catalytically essential dehydroalanine. J Biol Chem 1971; 246: 2977-2985.
26. Birkholz S, Knipp U, Lemma E, Kröger A, Opferkuch W. Fumarate reductase of Helicobacter pylori - an immunogenic protein. J Med Microbiol 1994; 41: 56-62.
27. 13C NMR spectroscopy. Microbiology 1994; 140: 2085-2092.
28. Hoffmann PS, Goodwin A, Johnsen J, Magee K, Veldhuyzen van Zanten SJO. Metabolic activities of metronidazole-sensitive and -resistant strains of Helicobacter pylori: repression of pyruvate oxidoreductase and expression of isocitrate lyase activity correlate with resistance. J Bacteriol 1996; 178: 4822-4829.
29. Salway JG. Metabolism at a glance. Oxford, Blackwell Science. 1994.
30. Newsholme P, Costa Rosa LFBP, Newsholme EA, Curi R. The importance of fuel metabolism in macrophage function. Cell Biochem Funct 1996; 14: 1-10.
31. Castell LM, Bevan SJ, Calder P, Newsholme EA. The role of glutamine in the immune system and in intestinal function in catabolic states. Amino Acids 1994; 7: 231-243.